EDAP TMS SA (EDAP) Covered Calls

EDAP TMS SA covered calls EDAP TMS S.A. develops, produces and markets minimally invasive medical devices, mainly for urological diseases. Its activity is organized in two divisions: HIFU and UDS.

You can sell covered calls on EDAP TMS SA to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for EDAP (prices last updated Tue 4:16 PM ET):

EDAP TMS SA (EDAP) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.32 -0.17 3.03 3.49 126K - 0.1B
Covered Calls For EDAP TMS SA (EDAP)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 20 3 0.20 3.29 -8.8% -803.0%
Aug 17 3 0.05 3.44 -12.8% -146.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

EDAP TMS SA develops, produces and markets minimally invasive medical devices for urological diseases. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer (stages T1-T2) who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment, Ablatherm-HIFU is approved and commercialized in Europe as a treatment for prostate cancer and is currently under regulatory review in the U.S. In March 2013, the company introduced a new innovative HIFU device, the Focal One dedicated to focal therapy of prostate cancer. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.